Eugene P. Frenkel
#139,288
Most Influential Person Now
Eugene P. Frenkel's AcademicInfluence.com Rankings
Eugene P. Frenkelengineering Degrees
Engineering
#5132
World Rank
#6376
Historical Rank
Biomedical Engineering
#366
World Rank
#375
Historical Rank
Eugene P. Frenkelphilosophy Degrees
Philosophy
#7197
World Rank
#10374
Historical Rank
Logic
#4263
World Rank
#5533
Historical Rank
Download Badge
Engineering Philosophy
Eugene P. Frenkel's Degrees
- PhD Biomedical Engineering University of California, Berkeley
- Doctorate Medicine Stanford University
Why Is Eugene P. Frenkel Influential?
(Suggest an Edit or Addition)Eugene P. Frenkel's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Circulating Tumor Cells in Patients with Breast Cancer Dormancy (2004) (873)
- Nanoparticles for drug delivery in cancer treatment. (2008) (723)
- HER-2 gene amplification can be acquired as breast cancer progresses. (2004) (560)
- Targeting renal cell carcinoma with a HIF-2 antagonist (2016) (485)
- Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients1 (2017) (393)
- Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. (2002) (366)
- Microchip-based immunomagnetic detection of circulating tumor cells. (2011) (361)
- Performance of four computer-based diagnostic systems. (1994) (317)
- Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. (1984) (253)
- Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset. (2013) (211)
- Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays (2000) (203)
- Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. (2003) (203)
- Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier. (1982) (188)
- Characterization of human neuroblastoma cell lines established before and after therapy. (1986) (175)
- Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma. (1986) (163)
- uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues (2006) (161)
- Malignant pineal region tumors. A clinico-pathological study. (1979) (152)
- Assessment of HER-2/neu status in breast cancer. Automated Cellular Imaging System (ACIS)-assisted quantitation of immunohistochemical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standard. (2001) (151)
- Elevated beta thromboglobulin in peripheral venous blood of patients with acute myocardial ischemia: direct evidence for enhanced platelet reactivity in vivo. (1981) (150)
- The atypical lymphocyte. (1967) (145)
- Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. (1988) (142)
- Aneusomy 17 in Breast Cancer: Its Role in HER-2/neu Protein Expression and Implication for Clinical Assessment of HER-2/neu Status (2002) (137)
- Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low‐risk clear cell renal cell carcinoma (2014) (136)
- Contemporary use of perioperative cisplatin‐based chemotherapy in patients with muscle‐invasive bladder cancer (2011) (135)
- Neurotoxicity of chemotherapeutic agents after blood‐brain barrier modification: Neuropathological studies (1983) (134)
- Developments in the diagnosis and treatment of primary CNS lymphoma: A prospective series (1986) (128)
- Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery. (1979) (125)
- Approach to the Assessment of Platelet Function: Comparison between Optical-based Platelet-rich Plasma and Impedance-based Whole Blood Platelet Aggregation Methods (2005) (121)
- Adenosine triphosphate-dependent transport of doxorubicin, daunomycin, and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein. (1994) (120)
- A Longitudinal Study of Adaptive Changes in Oxygen Transport and Body Composition (1968) (119)
- Thrombosis and a Hypercoagulable State in HIV-Infected Patients (2004) (118)
- Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation. (2003) (113)
- Synergy between methionine stress and chemotherapy in the treatment of brain tumor xenografts in athymic mice. (2001) (112)
- A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging. (1999) (111)
- Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression. (2016) (109)
- Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene. (2008) (106)
- Versatile immunomagnetic nanocarrier platform for capturing cancer cells. (2013) (105)
- PEGylation Confers Greatly Extended Half-Life and Attenuated Immunogenicity to Recombinant Methioninase in Primates (2004) (102)
- Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption. (1981) (100)
- Pharmacology and toxicity of intracarotid adriamycin administration following osmotic blood-brain barrier modification. (1981) (99)
- Effect of osmotic blood-brain barrier disruption on methotrexate pharmacokinetics in the dog. (1980) (96)
- Enhanced Chemosensitivity to Irinotecan by RNA Interference-Mediated Down-Regulation of the Nuclear Factor-κB p65 Subunit (2004) (93)
- Abnormal fatty acid metabolism in peripheral nerves of patients with pernicious anemia. (1973) (85)
- Molecular Detection of Noninvasive and Invasive Bladder Tumor Tissues and Exfoliated Cells by Aberrant Promoter Methylation of Laminin-5 Encoding Genes (2004) (84)
- In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5'-phosphate supplementation. (2003) (81)
- Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use. (2005) (79)
- Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening. (1984) (79)
- Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features. (2003) (76)
- Delivery of hexosaminidase A to the cerebrum after osmotic modification of the blood--brain barrier. (1981) (76)
- Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrier. (1985) (72)
- Epigenetic regulation of coxsackie and adenovirus receptor (CAR) gene promoter in urogenital cancer cells. (2003) (71)
- Successful treatment of primary central nervous system lymphomas with chemotherapy after osmotic blood-brain barrier opening (1983) (71)
- Antiphospholipid-thrombosis syndromes. (2003) (70)
- Antiphospholipid-Thrombosis Syndromes (1999) (70)
- Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain. (1985) (70)
- Thrombosis and hemorrhage in oncology patients. (1996) (70)
- Detection of tumor cells in the peripheral blood of nonleukemic patients with B-cell lymphoma: analysis of "clonal excess". (1980) (68)
- Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer. (2006) (67)
- Osmotic blood-brain barrier modification: clinical documentation by enhanced CT scanning and/or radionuclide brain scanning. (1983) (66)
- Cis‐platinum vestibular toxicity (1981) (65)
- Increased toxicity and lack of efficacy of Rofecoxib in combination with chemotherapy for treatment of metastatic colorectal cancer: A phase II study (2003) (65)
- Barbiturate inhibition of lymphocyte function. Differing effects of various barbiturates used to induce coma. (1982) (65)
- DNA methylation-associated inactivation of TGFβ-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers (2005) (64)
- Pharmacokinetics, Methionine Depletion, and Antigenicity of Recombinant Methioninase in Primates (2004) (64)
- Immunomagnetic nanoscreening of circulating tumor cells with a motion controlled microfluidic system (2013) (63)
- Selective toxicity of 6-hydroxydopamine and ascorbate for human neuroblastoma in vitro: a model for clearing marrow prior to autologous transplant. (1982) (63)
- Testicular tumors in men with human immunodeficiency virus. (1992) (61)
- Histone Deacetylase Inhibitor Romidepsin Enhances Anti-Tumor Effect of Erlotinib in Non-small Cell Lung Cancer (NSCLC) Cell Lines (2009) (60)
- Pharmacology and neurotoxicity of cis-diamminedichloroplatinum, bleomycin, 5-fluorouracil, and cyclophosphamide administration following osmotic blood-brain barrier modification. (1983) (59)
- Osmotic blood-brain barrier disruption in the posterior fossa of the dog. (1981) (59)
- Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors. (1981) (58)
- IκB Kinase α Regulates Subcellular Distribution and Turnover of Cyclin D1 by Phosphorylation* (2005) (57)
- Large cell lymphomas of the stomach: improved prognosis with complete resection of all intrinsic gastrointestinal disease. (1983) (57)
- The effect of vitamin B12 deprivation on the enzymes of fatty acid synthesis. (1973) (57)
- Using iron oxide nanoparticles to diagnose CNS inflammatory diseases and PCNSL (2013) (57)
- Purification and properties of acetyl coenzyme A synthetase from bakers' yeast. (1977) (56)
- STUDIES ON A METABOLIC DEFECT INDUCED BY HYDROXYUREA (NSC-32065). (1964) (55)
- Clopidogrel anti-platelet effect: An evaluation by optical aggregometry, impedance aggregometry, and the Platelet Function Analyzer (PFA-100™) (2007) (54)
- Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiency. (1983) (54)
- The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5‐azacytidine in human bladder cancer therapy (2007) (52)
- Delivery of active hexosaminidase across the blood‐brain barrier in rats (1984) (52)
- The frequency of anemia and iron deficiency in the runner. (1989) (52)
- Spontaneous fibrinolysis in pulmonary embolism. (1971) (49)
- Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice. (1968) (49)
- Osmotic blood-brain barrier disruption: a new means of increasing chemotherapeutic agent delivery. (1979) (49)
- Radioisotopic assay of serum vitamin B 12 with the use of DEAE cellulose. (1966) (49)
- The diagnostic dilemma of the “small round cell neoplasm”: Catecholamine fluorescence and tissue culture morphology as markers for neuroblastoma (1981) (49)
- Sticky platelet syndrome and thrombocythemia. (2003) (48)
- Use of enhanced computerized tomography to evaluate osmotic blood-brain barrier disruption (1980) (46)
- EFFECT OF X-RADIATION ON DNA METABOLISM IN VARIOUS TISSUES OF THE RAT. V. DNA METABOLISM IN REGENERATING THYMUS. (1963) (45)
- Disseminated Intravascular Coagulation (1999) (45)
- Chemotherapeutic agent permeability to normal brain and delivery to avian sarcoma virus-induced brain tumors in the rodent: observations on problems of drug delivery. (1984) (45)
- DNA methylation-associated inactivation of TGFβ-related genes, DRM/Gremlin, RUNX3, and HPP1 in human cancers (2013) (44)
- Immunoglobulin phenotype on B cells correlates with clinical stage of chronic lymphocytic leukemia. (1983) (44)
- Screening and Molecular Analysis of Single Circulating Tumor Cells Using Micromagnet Array (2015) (43)
- IgA antiphospholipid antibodies are an independent risk factor for thromboses (2008) (43)
- Acquired platelet dysfunction. (2007) (43)
- Successful treatment of primary central nervous system lymphomas with chemotherapy after osmotic blood-brain barrier opening. (1983) (43)
- Some observations concerning the demographic and geographic incidence of carcinoma of the lip and buccal cavity (1977) (42)
- Osmotic blood-brain barrier opening to IgM monoclonal antibody in the rat. (1986) (42)
- Molecular profiling of individual tumor cells by hyperspectral microscopic imaging. (2012) (41)
- IkappaB kinase alpha regulates subcellular distribution and turnover of cyclin D1 by phosphorylation. (2005) (41)
- Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma. (2015) (41)
- Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neck. (2001) (41)
- Is there a therapeutic role for blood-brain barrier disruption? (1980) (40)
- Acute lymphocytic leukemic transformation of chronic lymphocytic leukemia: Substantiation by flow cytometry (1981) (40)
- Associations between red cell glucose-6-phosphate dehydrogenase variants and vascular diseases. (1967) (39)
- Immune responses in patients with brain tumors: Factors such as anti‐convulsants that may contribute to impaired cell‐mediated immunity (1983) (39)
- Clinical Aspects of Heparin-Induced Thrombocytopenia and Thrombosis and other Side Effects of Heparin Therapy (1999) (38)
- Cerebrospinal fluid folate, and vitamin B 12 in anticonvulsant-induced megaloblastosis. (1973) (38)
- Recognition and resolution of errors in the radioisotopic assay of serum vitamin B12. (1970) (38)
- Suprasellar germinomas (ectopic pinealomas): aspects of immunological characterization and successful chemotherapeutic responses in recurrent disease. (1980) (38)
- Poor correlation of supratherapeutic international normalised ratio and vitamin K‐dependent procoagulant factor levels during warfarin therapy (2006) (37)
- Mechanism of increased coxsackie and adenovirus receptor gene expression and adenovirus uptake by phytoestrogen and histone deacetylase inhibitor in human bladder cancer cells and the potential clinical application. (2006) (37)
- Differential Methylation of a Short CpG-Rich Sequence within Exon 1 of TCF21 Gene: A Promising Cancer Biomarker Assay (2008) (36)
- Systematic siRNA Screen Unmasks NSCLC Growth Dependence by Palmitoyltransferase DHHC5 (2015) (35)
- Effect of vitamin B12 deprivation on the in vivo levels of coenzyme A intermediates associated with propionate metabolism. (1974) (35)
- Topoisomerase I inhibition with topotecan: pharmacologic and clinical issues (2001) (34)
- Clinical and laboratory features and sequelae of deficiency of folic acid (folate) and vitamin B12 (cobalamin) in pregnancy and gynecology. (2000) (33)
- Diamond-Blackfan syndrome in adult patients. (1985) (33)
- MRI evaluation of amyloid myopathy (2004) (33)
- An immunologic approach for the detection of tumor cells in the peripheral blood of patients with malignant lymphoma; implications for the diagnosis of minimal disease. (1979) (33)
- Inability of dimethyl sulfoxide and 5-fluorouracil to open the blood-brain barrier. (1983) (33)
- Hereditary nonspherocytic hemolysis with erythrocyte phosphofructokinase deficiency. (1972) (32)
- The control of iron absorption by the gastrointestinal mucosal cell. (1972) (32)
- Skeletal muscle lymphoma: MRI evaluation. (1992) (32)
- Cis‐platinum induction chemotherapy in the multi‐modality initial treatment of advanced stage IV carcinoma of the head and neck (1983) (31)
- A simplified and rapid quantitative assay for propionic and methylmalonic acids in urine. (1975) (31)
- Toxicity of indium-111 on the radiolabeled lymphocyte. (1987) (30)
- Thrombocytopenia. Issues in diagnosis and therapy. (1994) (30)
- Comparison of a rapid platelet function assay--Verify Now Aspirin--with whole blood impedance aggregometry for the detection of aspirin resistance. (2007) (30)
- The paradoxical effect of bevacizumab in the therapy of malignant gliomas (2011) (30)
- Analysis of Thrombophilia Test Ordering Practices at an Academic Center: A Proposal for Appropriate Testing to Reduce Harm and Cost (2016) (29)
- Acute leukemia and pregnancy. (1960) (29)
- Glutathione and glutathione linked enzymes in human small cell lung cancer cell lines. (1993) (28)
- The role of chemotherapy in head and neck cancer. (1997) (28)
- The clinical spectrum of thrombocytosis and thrombocythemia. (1991) (28)
- Evaluation of bone marrow iron stores in anemia associated with chronic disease: A comparative study of serum and red cell ferritin (1993) (28)
- Mode of action of anti-lymphocyte globulin. II. Changes in the lymphoid cell population in rats treated with anti-lymphocyte globulin. (1968) (27)
- Targeting methionine auxotrophy in cancer: discovery & exploration (2012) (27)
- MEGALOBLASTIC ERYTHROPOIESIS INDUCED BY HYDROXYUREA (NSC-32065). (1964) (26)
- The effect of immunologically induced lymphopenia on antibody formation. (1969) (26)
- Trace metals in hematopoiesis (1981) (26)
- The application of epigenetic modifiers on the treatment of prostate and bladder cancer. (2006) (26)
- Frequent detection of infectious xenotropic murine leukemia virus (XMLV) in human cultures established from mouse xenografts (2011) (26)
- High-performance liquid chromatographic separation of cobalamins. (1979) (26)
- Studies of the mechanism by which hepatic citrate synthase activity increases in vitamin B12 deprivation. (1976) (25)
- Circulating Half-Life of PEGylated Recombinant Methioninase Holoenzyme Is Highly Dose Dependent on Cofactor Pyridoxal-5′-Phosphate (2004) (25)
- Biochemical and ultrastructural hepatic changes during vitamin B12 deficiency in animals and man. (1976) (24)
- Is there a "gold standard" for human serum vitamin B12 assay? (1984) (24)
- Induced ribotide reductive conversion defect by hydroxyurea and its relationship to megaloblastosis. (1967) (24)
- Enhanced transgene expression in androgen independent prostate cancer gene therapy by taxane chemotherapeutic agents. (2002) (24)
- Intracellular Localization of Hepatic Propionyl‐CoA Carboxylase and Methylmalonyl‐CoA Mutase in Humans and Normal and Vitamin B12 Deficient Rats (1975) (23)
- Myoglobinuria after spontaneous and induced fever: report of a case. (1958) (23)
- Therapeutic dilemma of disseminated CNS germinoma and the potential of increased platinum-based chemotherapy delivery with osmotic blood-brain barrier disruption. (1994) (23)
- Studies of the effect of induced immune lymphopenia. I. Enhanced effects of rabbit anti-rat lymphocyte globulin in rats tolerant to rabbit immunoglobulin G. (1967) (23)
- Nodular regenerative hyperplasia of the liver in a case of myelofibrosis with extramedullary hematopoiesis and secondary portal venous hypertension. (1979) (23)
- Measurement of tissue vitamin B12 by radioisotopic competitive inhibition assay and quantitation of tissue cobalamin fractions. (1980) (23)
- Hyperhomocysteinemia and thrombosis. (2003) (22)
- Growth characteristics of neuroblastoma in vitro correlate with patient survival. (1980) (22)
- EFFECT OF X-RADIATION ON DNA METABOLISM IN VARIOUS TISSUES OF THE RAT. VI. CORRELATIVE MORPHOLOGIC AND BIOCHEMICAL CHANGES DURING THE REGENERATION OF THE THYMUS. (1963) (22)
- Treatment of cutaneous sclerosis and aplastic anemia with antithymocyte globulin. (1987) (22)
- Gaucher disease: a heterogeneous clinical complex for which effective enzyme replacement has come of age. (1993) (21)
- On the counting of tritiated thymidine in tissues. (1962) (21)
- Enhanced therapeutic effect on androgen-independent prostate cancer by depsipeptide (FK228), a histone deacetylase inhibitor, in combination with docetaxel. (2007) (20)
- Evaluation of a packaged kit assay of serum ferritin and application to clinical diagnosis of selected anemias. (1978) (20)
- Reversible Renal Toxicity Resulting From High Single Doses of the New Radiosensitizer Gadolinium Texaphyrin (2000) (20)
- An unusual case of macroglobulinemia. (1967) (19)
- The Impact of Dose Intensity of Standard Chemotherapy Regimens in Extensive Stage Small Cell Lung Cancer (1993) (19)
- Cells Lacking IKKα Show Nuclear Cyclin D1 Overexpression and a Neoplastic Phenotype: Role of IKKα as a Tumor Suppressor (2011) (19)
- Detection and Staging of Small Cell Lung Carcinoma with a Technetium‐labeled Monoclonal Antibody A Comparison with Standard Staging Methods (1992) (19)
- Hematological complications in obstetrics, pregnancy, and gynecology (2006) (19)
- The relationship of doxorubicin binding to membrane lipids with drug resistance. (1992) (19)
- NATURAL HOST RESISTANCE TO INFECTION WITH CRYPTOCOCCUS NEOFORMANS. III. THE EFFECT OF CRYPTOCOCCAL POLYSACCHARIDE UPON THE PHYSIOLOGY OF THE RETICULOENDOTHELIAL SYSTEM OF LABORATORY ANIMALS. (1964) (18)
- Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy (2006) (18)
- The relative value of conventional staging procedures for developing prognostic models in extensive-stage small-cell lung cancer. (1990) (18)
- Upregulation of TRAG3 gene in urothelial carcinoma of the bladder (2011) (17)
- SOME OBSERVATIONS ON THE LOCALIZATION OF ERYTHROPOIETIN (1968) (17)
- Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other adverse effects of heparin-type therapy. (2003) (16)
- Fecal blood loss following aspirin and coated aspirin microspherule administration. (1968) (16)
- Translocation (3;21)(q26;q22) in secondary leukemia. Report of two cases and literature review. (1991) (16)
- Cobalamin profiles in patients after urinary diversion. (2002) (16)
- Extraction and quantification of daunomycin and doxorubicin in tissues. (1980) (16)
- The Clinical Spectrum of Light Chain Myeloma. (1972) (15)
- Meningoencephalitis in infectious mononucleosis; report of a case treated with cortisone. (1956) (15)
- Acute subdural hematomas with lupus anticoagulant (procoagulant inhibitor) (1984) (14)
- [38] Acetyl-CoA synthetase from bakers' yeast (Saccharomyces cerevisiae): EC 6.2.1.1 acetate:CoA ligase (AMP-forming) (1981) (14)
- The Challenge of the Blood-Brain Barrier (1989) (14)
- The effect of running on serum and red cell ferritin. A longitudinal comparison. (1995) (13)
- Effect of Trans-2,3-Dimethoxycinnamoyl Azide on Enhancing Antitumor Activity of Romidepsin on Human Bladder Cancer (2008) (13)
- Comparison of two methods for radioassay of vitamin B12 in serum. (1973) (13)
- Applicability of an enzymatic quantitation of methylmalonic, propionic, and acetic acids in normal and megaloblastic states. (1977) (13)
- Influence of hemoglobin phenotype on the mean erythrocyte volume. (1983) (13)
- An analysis of methods for the prediction of normal erythrocyte mass. (1972) (12)
- Elevated serum acid phosphate associated with multiple myeloma. Case report with tissue enzyme assay. (1962) (12)
- Prothrombin G20210A gene mutation, heparin cofactor II defects, primary (essential) thrombocythemia, and thrombohemorrhagic manifestations. (1999) (12)
- Molecular heterogeneity in adjacent cells in triple-negative breast cancer (2015) (12)
- The direct thrombin inhibitors: their role and use for rational anticoagulation. (2005) (12)
- MULTIPLE MYELOMA. STUDIES OF MOUSE PLASMA CELL TUMOR AND HUMAN MYELOMA RESPONSIVENESS TO CYCLOPHOSPHAMIDE (CYTOXAN). (1964) (12)
- Preclinical antitumor activity of S-222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2 (2014) (12)
- USE OF ENHANCED COMPUTERIZED TOMOGRAPHY TO EVALUATE OSMOTIC BLOOD–BRAIN BARRIER DISRUPTION (1981) (11)
- An isotopic measurement of vitamin B12 in cerebrospinal fluid. (1971) (11)
- Cranial Nerve Deficits Due to Amyloidosis Associated With Plasma Cell Dyscrasia (1986) (11)
- Effect of vitamin B-12 deprivation on the rates of synthesis and degradation of rat liver fatty acid synthetase. (1974) (11)
- Issues of thrombosis and hemorrhagic events in patients with cancer. (1998) (10)
- Characterization of an animal model of vitamin B12 deprivation. (1973) (10)
- Anemia of malignancy. (1996) (10)
- Radionuclide Imaging of Bone Marrow Metastases with a Tc‐99m Labeled Monoclonal Antibody to Small Cell Lung Carcinoma (1991) (10)
- Palatine petechiae, an early sign in infectious mononucleosis. (1956) (10)
- Seven-week continuous-infusion paclitaxel with concurrent radiotherapy for locally advanced head and neck squamous cell cancer: a phase I study. (1997) (9)
- Soluble fibrin complexes in experimental thrombotic states. (1974) (9)
- OSMOTIC BLOOD‐BRAIN BARRIER DISRUTPION (1980) (9)
- Effect of the radiolabel mediator tropolone on lymphocyte structure and function. (1986) (9)
- CHEWING TOBACCO AND RADIOIODINE (1967) (9)
- Percutaneous absorption and elimination of an aromatic hair dye. (1973) (9)
- Enzymatic properties of mitochondria isolated from normal and vitamin B12-deficient rats. (1979) (9)
- MIB1 Labeling Index as an Indicator of Chemoresponse in Carcinoma of the Breast (2004) (8)
- Therapeutic plasma exchange in the immune hemolytic anemias and immunologic thrombocytopenic purpura. (1982) (8)
- Platelet aggregation responses vary over a period of time in healthy controls (2010) (7)
- Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumours. (2015) (7)
- Effect of vitamin B-12 deficiency on the hepatic tissue concentration of acyl carnitines. (1975) (7)
- A case of autoimmune severe acquired von Willebrand syndrome (type 3-like). (2017) (7)
- Probable myeloblastic leukemoid reaction with disseminated sarcoidosis. (1977) (7)
- L-Asparaginase-Provoked Seizures as Singular Expression of Central Nervous Toxicity (2000) (7)
- Radioisotopic assay of vitamin B12 in tissues. (1976) (7)
- Reversible osmotic blood-brain barrier disruption in humans: implications for the chemotherapy of malignant brain tumors. (1980) (6)
- Comparative Effects of Methylmalonyl Coenzyme A on Fatty Acid Synthetase Derived From Rat and Man 1 (1977) (6)
- Treatment of “poor risk” acute nonlymphocytic leukemia with continuously infused low‐dose cytosine arabinoside (1988) (6)
- Double modulation of 5-fluorouracil in the treatment of advanced colorectal carcinoma: report of a trial with sequential methotrexate, intravenous (loading dose) folinic acid, 5-fluorouracil, and a literature review. (1994) (5)
- Phase I expansion of S-222611, a reversible inhibitor of EGFR and HER2, in advanced solid tumors, including patients with brain metastases. (2015) (5)
- Physiology of Hemostasis and Thrombosis. (1968) (5)
- Erratum: DNA methylation-associated inactivation of TGFβ-related genes, DRM/Gremlin, RUNX3, and HPP1 in human cancers (British Journal of Cancer (2005) 93 (1029-1037) DOI: 10.1038/sj.bjc.6602837) (2013) (5)
- Analysis and detection of B cell neoplasms. (1980) (5)
- ERYTHROKINETIC ABNORMALITIES WITH ADMINISTRATION OF HYDROXYUREA (NSC-32065). (1964) (4)
- Response of the Thymus and Immunologically Induced Lymphopenia.∗ (1967) (4)
- Erratum: Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low‐risk clear cell renal cell carcinoma (2014) (4)
- Metagenomic shotgun sequencing to identify specific human gut microbes associated with immune checkpoint therapy efficacy in melanoma patients. (2017) (4)
- Bacteria as Specific Binding Agents for an Isotopic Assay of Serum Folate (1970) (4)
- Lack of effect of riboflavin deficiency on vitamin B12-related metabolic pathways and fatty acid synthesis. (1979) (3)
- Quantitative monitoring of lymphoid malignancies. Application and findings in chronic lymphocytic leukemia. (1983) (3)
- Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56 subset (2013) (3)
- Therapeutic plasmapheresis in patients with antibodies to high-frequency red cell antigens. (1982) (3)
- Training and practice activities of hematology and medical oncology diplomates. (1990) (3)
- Acetyl-CoA synthetase from bakers' yeast (Saccharomyces cerevisiae). (1981) (3)
- The rationale and approach to immunosuppressive therapy. (1971) (3)
- Phase I Dose Escalation Study With Irinotecan, Capecitabine, Epirubicin, and Granulocyte Colony-Stimulating Factor Support for Patients With Solid Malignancies (2008) (3)
- A phase I study of S-222611 an oral reversible dual inhibitor of EGFR and HER2, in patients with solid tumors. (2012) (2)
- Patterned nanomagnets on-chip for screening circulating tumor cells in blood (2012) (2)
- The Prevalence and Clinical Significance of IgA Antiphospholipid Antibodies (aPL). (2005) (2)
- Hypoerythropoietinemia and anemia. (1970) (2)
- Incidence of Isolated Heparin-Induced Thrombocytopenia and Risk of Thrombosis by IgG-Specific Anti-PF4/Heparin ELISA (2012) (2)
- In-vivo evaluation of human recombinant Co-arginase against A375 melanoma xenografts (2014) (2)
- The DNA of the inflammatory cell in repair. (1965) (2)
- Low Risk 4T Score Can Rule out Heparin-Induced Thrombocytopenia. (2009) (1)
- Initial clinical studies of chemotherapy delivery to brain tumor patients after osmotic blood brain barrier modification (1981) (1)
- Abstract P4-14-26: Phase I expansion of S-222611, a reversible inhibitor of EGFR and HER2, in advanced solid tumors, including HER2-positive breast cancer patients with brain metastases (2016) (1)
- THE CLINICAL APPLICATION OF THYROID STIMULATION AND SUPPRESSION TESTS (1962) (1)
- Melanoma Metamorphoses: Advances in Biology and Therapy (2017) (1)
- Total Methionine Restriction Treatment of Cancer. (2019) (1)
- Initial Management of Suspected Heparin-Induced Thrombocytopenia: Opportunities for Education (2011) (1)
- Immunomagnetic nanoscreening of circulating tumor cells with a motion controlled microfluidic system (2012) (1)
- Clinical forms of chronic lymphocytic leukemia. Implications for prognosis and therapy. (1984) (1)
- Neurotoxicity of adriamycin infusion following osmotic blood brain barrier (1981) (1)
- Book Review (2008) (1)
- Erratum: IκB kinase α regulates subcellular distribution and turnover of cyclin D1 by phosphorylation (Journal of Biological Chemistry (2005) 280 (33945-33952)) (2005) (1)
- Abstract 4292: Frequent detection of xenotropic murine leukemia virus (XMLV) strains including XMRV in human cultures established from mouse xenografts (2011) (1)
- Academic Cancer Center Phase I Program Development (2017) (1)
- Phase I and pharmacodynamic study of the histone deacetylase (HDAC) inhibitor romidepsin plus erlotinib in previously treated advanced non-small cell lung cancer (NSCLC). (2013) (1)
- Newer Anticancer Drugs and Procedures. (1974) (1)
- Phenotype on B Cells Correlates With Clinical Stage of Chronic Lymphocytic Leukemia (2011) (1)
- Effects of heterologous transplantation of a mouse plasmacytoma. I. Runting syndrome secondary to malignant tumors. (1962) (1)
- Tumors in the central nervous system: current issues and lessons for the internist (1983) (1)
- Lupus Anticoagulant Interference in Activated Protein C Resistance Testing (2011) (1)
- Multi-laboratory evaluation of 'serum vitamin B12 level' measured by radioassay for 'total B12' vs. 'true cobalamin' vs. microbiologic assay with Euglena gracilis (1979) (0)
- Traitements combinés contre le cancer (2008) (0)
- Incidence of Isolated Heparin-Induced Thrombocytopenia and the Risk of Developing Subsequent Thrombosis Using the New IgG Specific Anti-PF4/Heparin ELISA (2010) (0)
- Medication-Induced Bleeding Disorders (1988) (0)
- Pleurisy with effusion due to remote trauma; a differential diagnosis for acute idiopathic pleural effusion. (1957) (0)
- Heparin-induced thrombocytopenia in pregnancy (2006) (0)
- The effects of osmotic modification of the blood-brain barrier and adrenal steroid administration on methotrexate delivery to rodent gliomas (1981) (0)
- IκB kinase α regulates subcellular distribution and turnover of cyclin D1 by phosphorylation. VOLUME 280 (2005) PAGES 33945-33952 (2005) (0)
- CLINICAL AND LABORATORY FEATURES AND SEQUELAE OF DEFICIENCY OF FOLIC ACID (COBALAMIN) IN PREGNANCY AND GYNECOLOGY (FOLATE) AND VITAMIN Biz (2000) (0)
- An Anti-Phosphatidylserine (PS) Antibody, Tarvacin™ That Targets Tumor Blood Vessels Does Not Affect Platelet Function In Vitro. (2005) (0)
- Cancer incidence rates in the Dallas-Fort Worth metropolitan area. (1975) (0)
- S‐222611, an oral reversible tyrosine kinase inhibitor of EGFR and HER2. A representative histological image of the colon treated with S‐222611 (25 mg/kg) (2014) (0)
- CLINICOPATHOLOGIC CONFERENCE. (1964) (0)
- The direct thrombin inhibitors (2005) (0)
- When chemotherapy fails: mechanisms of drug resistance and their relationship to carcinogenesis (1988) (0)
- Induced Riboti de Reductive Conversion Defect by Hydroxyurea and Its Relationship to Megaloblastosis 1 (2006) (0)
- Richard Louis Potter (1918-1960) (2010) (0)
- 961: Upregulation of Coxsackie and Adenovirus Receptor Gene Expression by Novel Chemotherapeutic Agents in Bladder Cancer Cells (2004) (0)
- Systematic siRNAScreenUnmasksNSCLCGrowth Dependence by Palmitoyltransferase DHHC 5 (2015) (0)
- 960: New Therapeutic Regimen for Transitional Cell Carcinoma Targeting the Epigenetic Gene Regulatory Machinery in Vitro and in Vivo (2004) (0)
- V. DNA Metabolism in Regenerating Thymus (2016) (0)
- 52 Attenuated immunogenicity and toxicity of PEGylated recombinant methioninase (PEG-rMETase) in primates (2004) (0)
- Impedance-Based Whole Blood and Optical-Based Platelet Rich Plasma Aggregation Methods for the Assessment of Celexocib Effects on Platelet Function: A Preliminary Report. (2004) (0)
- Clinicopathologic conference. (1970) (0)
- Hematological Complications in Obstetrics, Pregnancy, and Gynecology: Preface (2006) (0)
- Comparison of Rapid Platelet Function Assay with Whole Blood Platelet Impedance Aggregometry for the Definition of Aspirin Resistance. (2005) (0)
- Thrombocytopenia in pregnancy (2006) (0)
- Abstract LB-85: Ectopic expression of eukaryotic translation elongation factor eEF1A2 is a hallmark for human lung cancer and is associated with poor prognosis (2012) (0)
- C1LC20270G 3449..3457 (2011) (0)
- on the RadiolabeledLymphocyte (1987) (0)
- And, more on: assessing aspirin responsiveness using the verify now aspirin assay. (2008) (0)
- Some clinical aspects of platelet diseases (1963) (0)
- Recent Developments in Multiple Myeloma. (1962) (0)
- Comparative radioassay methods for the determination of serum vitamin B12 (1973) (0)
- A correlative study of mouse myeloma and human melanoma treated with cyclophosphamide. (1962) (0)
- The paradoxical effect of targeted antivascular agents in the therapy of CNS malignancies. (2009) (0)
- Comprar Hematological Complications in Obstetrics, Pregnancy, and Gynecology | Rodger L. Bick | 9780521108690 | Cambridge University Press (2009) (0)
- Mutation and gene copy number of KRAS, BRAF, HER2 and PIK3CA in colorectal cancer (2008) (0)
- Seminar article The application of epigenetic modifiers on the treatment of prostate and bladder cancer (2006) (0)
- Analysis of Ordering Practice of Thrombophilia Testing at a Single Large Teaching Hospital (2010) (0)
- Carcinoma of the prostate: controversies and dilemmas (1985) (0)
- Seminar article Nanoparticles for drug delivery in cancer treatment (2008) (0)
- Hematology-oncology. Hematology-Oncology Workgroup, Legislative Task Force on Cancer in Texas. (1987) (0)
- Clinicopathologic conference. (1967) (0)
- Heparin-Induced Thrombocytopenia Antibody Is More Common in Patients with Active Bacterial Infections (2011) (0)
- CLINICOPATHOLOGIC CONFERENCE. (1965) (0)
- Chronic granulocytic leukemia (chronic myelogenous leukemia) (1975) (0)
- 88 NEUROTOXICITY OF ADRIAMYCIN INFUSION FOLLOWING OSMOTIC BLOOD BRAIN BARRIER DISRUPTION IN THE CANINE (1981) (0)
- diseases and PCNSL Using iron oxide nanoparticles to diagnose CNS inflammatory (0)
- Comparison of Two Methods for Radioassay of Vitamin B 12 in Serum (2004) (0)
- Retraction notice to “Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer” [Cancer Lett. 242 (2) (2006) 222–230]. Makoto Suzuki, Hisayuki Shigematsu, Narayan Shivapurkar, Jyotsna Reddy, Kuniharu Miyajima, Takao Takahashi, Adi F. Gazdar, Eugene P. Frenke. (2015) (0)
- Granulocyte transfusion therapy. (1977) (0)
- Phosphofructokinase Deficiency Hereditary Nonspherocytic Hemolysis With Erythrocyte (2011) (0)
- Optical Density of 1.0 Is a Better Cutoff for Positive HIT Ab ELISA. (2009) (0)
- Identification and Validation of Genes Involved in the Pathogenesis of Colorectal Cancer Using cDNA Microarrays and RNA Interference 1 (2003) (0)
- Blood Transfusion in Clinical Medicine. (1966) (0)
- Opsonic Property of Multiple Myeloma Serum.∗ (1967) (0)
- Successful use of chemotherapy after osmotic blood-brain disruption in the treatment of microgliomas (1982) (0)
- 364 A rapid immunoassay for quantitating free and bound plasma proteins (1988) (0)
- The Effect of Vitamin B , , Deprivation on the Enzymes of Fatty Acid Synthesis (2003) (0)
- SERUM AND RED CELL FERRITIN : DIAGNOSTIC TOOLS AND PATHOPHYSIOLOGIC CLUES.AUTHOR'S REPLY (1994) (0)
- Response of the thymus and immunologically induced lymphopenia. (1968) (0)
- Hematological Complications in Obstetrics, Pregnancy, and Gynecology: Plate section (2006) (0)
- Utility of iron oxide nanoparticles in the radiographic diagnosis of CNS lymphoma and inflammatory diseases. (2012) (0)
- Acquired hypoplastic anemia: (aplastic anemia or bone marrow failure) (1972) (0)
- With Erythrocyte Phosphofructokinase Deficiency (2005) (0)
- Methods for Vitamin B 12 Assay: Some Comments (1972) (0)
- Deregulation of genes related to TGF-β signaling pathway via aberrant methylation in human cancers (2004) (0)
- The treatment of classical hemophilia with factor 8 concentrates. (1968) (0)
- The Significance of the Acanthocyte in Cirrhosis with Hemolytic Anemia. (1968) (0)
- Autoimmune hemolytic anemia (1968) (0)
- BOOK REVIEWS/BUCHBESP RECHUNGEN (1981) (0)
- Elevated Serum Acid (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Eugene P. Frenkel?
Eugene P. Frenkel is affiliated with the following schools:
